Skip to research content
Back to insiders

Robert Molander

Follow this party across linked issuers and source filings.

PartySE · FISweden public disclosures

Companies in disclosed relationships

1

Public filings · 12 months

0

Net disclosed balance · 12 months

€0.00

Latest filing

6 Mar 2024

Signals are not available for this disclosure jurisdiction.

Recent filings

All disclosed operations, including compensation and transfers. Values can represent transferred assets rather than cash invested.

Recent public filings linked to this insider party
DateCompanyGross reported valueOpen
6 Mar 2024
Modification
Corrects#A003B156-1
XSpray Pharma AB (publ)Buy

US$19,900.00

Buy/sale net: US$19,900.00
Open
2 Mar 2023XSpray Pharma AB (publ)Buy

US$19,230.00

Buy/sale net: US$19,230.00
Open
1 Mar 2023XSpray Pharma AB (publ)Buy

US$12,935.40

Buy/sale net: US$12,935.40
Open
Buy

Gross reported value

US$19,900.00

Modification
Corrects#A003B156-1
Evidence
Buy

Gross reported value

US$19,230.00

Evidence
Buy

Gross reported value

US$12,935.40

Evidence

Network and companies

1 distinct company in the disclosed relationships. Network coverage is a separate preview.